SEARCH

SEARCH BY CITATION

References

  • 1
    Demetris AJ, Jaffe R, Tzakis A, Ramsey G, Todo S, Belle S et al. Antibody-mediated rejection of human orthotopic liver allografts A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988;132:489502.
  • 2
    Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990;336:51923.
  • 3
    Farges O, Kalil AN, Samuel D, Saliba F, Arulnaden JL, Debat P et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995;59:112433.
  • 4
    Kiuchi T, Tanaka K. Living-related donor liver transplantation: Status Quo in Kyoto, Japan. Transplant Proc 1998;30:68791.
  • 5
    Alexandre GPJ, Squiffl Et JP, De Bruyere M, Latinne D, Morian M, Ikebu N et al. Splenectomy as a prerequisiste for successful human ABO-incompatible renal transplantation. Transplant Proc 1985;17:13843.
  • 6
    Egawa H, Oike F, Buhler L, Shapiro AM, Minamiguchi S, Haga H et al. Impact of recipient age on outcome of ABO-incopatible living-donor liver transplantation. Transplantation 2004;77:40311.
  • 7
    Toso C, Al-Qahtani M, Alsaif FA, Bigam DL, Meeberg GA, James Shapiro AM et al. ABO-incompatible liver transplantation for critically ill adult patients. Transpl Int 2007;20:67581.
  • 8
    Pratschke J, Tullius SG. Promising recent data on ABO incompatible liver transplantation: restrictions may apply. Transpl Int 2007;20:6478.
  • 9
    Takahashi K, Yagisawa T, Sonda K, Kawaguchi H, Yamaguchi Y, Toma H et al. ABO-incompatible kidney transplantation in a single-center trial. Transplant Proc 1993;25:2713.
  • 10
    Saito K, Takahashi K. ABO-incompatible kidney transplantation. In: TakahashiK, TanakaK, editors. New Strategies for ABO-incompatible Kidney Transplantation 2008. Tokyo: Nihon Igakukan; 2008: pp 317.
  • 11
    Toma H. ABO-incompatible renal transplantation. Urol Clin North Am 1994;21:299.
  • 12
    Tanabe M, Shimazu M, Wakabayashi G, Hoshino K, Kawachi S, Kadomura T et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002;73:195961.
  • 13
    Takaya S, Iwaki Y, Starzl TE. Liver transplantation in positive cytotoxic crossmatch cases using FK 506, high-dose steroids, and prostaglandin E1. Transplantation 1992;54:9279.
  • 14
    Takenaka N, Shimada Y, Hirata T, Nishijima MK, Takezawa J, Yoshiya I et al. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis. Crit Care Med 1983;11:735.
  • 15
    The Japanese Liver Transplantation Society. Liver transplantation in Japan-registry by the Japanese Liver Transplantation Society (in Japanese with English abstract). Isyoku 2005;40:51826.
  • 16
    Kozaki K, Egawa H, Kasahara M, Oike F, Yoshizawa A, Fukatsu A et al. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Ther Apher Dial 2005;9:28591.
  • 17
    Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008;47:14352.
  • 18
    Takahashi K. Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol 2007;11:12841.
  • 19
    Takahashi K. A new concept of accommodation in ABO incompatible kidney transplantation. Clin Transplant 2005;19(Suppl. 14):7685.
  • 20
    Zecca M, De Stefano P, Nobili B, Locatelli F. Anti-CD20 monoclonal antibody for the treatment of severe, immunemediated, pure red cell aplasia and hemolytic anemia. Blood 2001;97:39957.
  • 21
    Sawada T, Fuchimoto S, Teraoka S. Successful A1 to O, ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double filtration plasmapheresis. Transplantation 2002;74:120710.
  • 22
    Gloor JM, DeGoey SR, Pineda AA, Moore SB, Prieto M, Nyberg SL et al. Overcoming a positive crossmatch in living-donor kidney transplantation Am J Transpl 2003;3:101723.
  • 23
    Pierson RN III, Loyd JE, Goodwin A, Majors D, Dummer JS, Mohacsi P et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, compliment inhibition, and immunomodulatory therapy. Transplantation 2002;74:7984.
  • 24
    Aranda JM, Scornik JC, Normann SJ, Lottenberg R, Schofield RS, Pauly DF et al. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 2002;73:90710.
  • 25
    Egawa H. Japanese ABO-incompatible transplantation committee. Japanese registry of ABO-incompatible living-donor liver transplantation 2008. In: TakahashiK, TanakaK, editors. New Strategies for ABO Incompatible Transplantation 2009. Tokyo: Nihon Igakukan, 2009:6870.
  • 26
    Usuda M, Fujimori K, Koyamada N, Fukumori T, Sekiguchi S, Kawagishi N et al. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible livingrelated liver transplantation. Transplantation 2005;79:126.
  • 27
    Monteiro I, McLoughlin L, Fisher A, De La Torre AN, Koneru Baburao. Rituximab with plasmapheresis and splenectomy in ABO-incompatible liver transplantation. Transplantation 2003;76:16489.
  • 28
    Egawa H, Ohmori K, Haga H, Tsuji H, Yurugi K, Miyagawa-Hayashino A et al. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transpl 2007;13:57988.
  • 29
    Takahashi K. Effects and complications of splenectomy. In: TakahashiK, editor. Accommodation in ABO-incompatible Kidney Transplantation. Amsterdam: Elsevier; 2004 Chap. 7: pp 813.
  • 30
    Mor E, Skerrett D, Manzarbeitia C, Sheiner PA, Schwartz M, Emre S et al. Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation 1995;59:98690.
  • 31
    Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Harada N et al. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Transplantation 2009;88:3037.
  • 32
    Jordan S, Cunningham-Rundles C, McEwan R. Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications. Am J Transplant 2003;3:65364.
  • 33
    Urbani L, Mazzoni A, Bianco I, Grazzini T, De Simone P, Catalano G et al. The role of immunomodulation in ABO-incompatible adult liver transplant recipients. J Clin Apher 2008;23:5562.
  • 34
    Tanaka K, Ozawa K, Teramukai S, Takada Y, Egawa H, Kaihara S et al. Classification of human liver transplant recipients by their preoperative CD8 cell subpopulation and its relation to outcome. Liver Transpl 2006;12:792800.
  • 35
    Tanaka K, Uemoto S, Egawa H, Takada Y, Ozawa K, Teramukai S et al. Cytotoxic T-cell-medicated defense against infections in human liver transplant recipients. Liver Transpl 2007;13:28793.
  • 36
    Egawa H, Ozawa K, Takada Y, Teramukai S, Mori A, Kasahara M et al. Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT. Dig Dis Sci 2009;54:225363.
  • 37
    Ohdan H, Zhou W, Tanaka Y, Irei T, Fuchimoto Y, Egawa H et al. Evidence of immune tolerance to blood group antigens in a case of ABO-incompatible pediatric liver transplantation. Am J Transplant 2007;7:21904.
  • 38
    Haga H, Egawa H, Shirase T, Miyagawa A, Sakurai T, Minamiguchi S et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl 2004;10:1627.
  • 39
    Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl 2006;12:45764.